衣原体与淋球菌感染及重复检测与盆腔炎风险:基于人群的队列研究
该研究基于澳大利亚西部315123名女性队列,链接2002至2013年衣原体和淋球菌检测及盆腔炎就诊记录,采用时变生存分析。调整年龄等因素后,淋球菌阳性者盆腔炎风险显著高于衣原体阳性者,双重感染者风险亦高。淋球菌耐药可能加重盆腔炎负担。
要点
- 淋球菌感染者的盆腔炎风险高于衣原体感染者。
- 双重感染者盆腔炎风险亦显著升高。
- 淋球菌耐药可能影响盆腔炎及其生殖健康后遗症。
核心结论
- 淋球菌感染导致盆腔炎住院或急诊就诊的风险显著高于衣原体感染。
研究设计与样本
- 基于人群的队列研究,纳入315123名1974至1995年出生的澳大利亚西部女性,概率链接2002至2013年检测与就诊记录,使用时变生存分析。
主要发现
- 共3199135人年随访,120748名女性同时有衣原体和淋球菌检测记录,10745名仅衣原体检测,653名仅淋球菌检测。
- 检测者中16778名(12.8%)至少一次衣原体阳性,3195名(2.6%)至少一次淋球菌阳性,1874名(1.6%)两者均阳性。
- 共4819次盆腔炎就诊(2222次住院,2597次急诊)。
- 调整年龄、原住民身份、随访年份、健康区域和社会经济状态后,相比双阴性女性,双重阳性者盆腔炎调整发病率比为4.29(95%CI 3.66-5.03),仅淋球菌阳性者为4.54(95%CI 3.87-5.33),仅衣原体阳性者为1.77(95%CI 1.61-1.94)。
临床怎么用
- 临床应重视淋球菌感染的盆腔炎风险,对淋球菌阳性者加强随访和盆腔炎筛查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is uncertainty around whether the risks of pelvic inflammatory disease (PID) differ following Chlamydia trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhea) infection. We quantified the risk of PID associated with chlamydia and gonorrhea infection and subsequent repeat infections in a whole-population cohort. METHODS: A cohort of 315123 Western Australian women, born during 1974-1995, was probabilistically linked to chlamydia and gonorrhea testing records and to hospitalizations and emergency department presentations for PID from 2002 to 2013. Time-updated survival analysis was used to investigate the association between chlamydia and gonorrhea testing, and positivity, and risk of PID. RESULTS: Over 3199135 person-years, 120748 women had pathology test records for both chlamydia and gonorrhea, 10745 chlamydia only, and 653 gonorrhea only. Among those tested, 16778 (12.8%) had ≥1 positive chlamydia test, 3195 (2.6%) ≥1 positive gonorrhea test, and 1874 (1.6%) were positive for both. There were 4819 PID presentations (2222 hospitalizations, 2597 emergency presentations). Adjusting for age, Aboriginality, year of follow-up, health area, and socioeconomic status, compared to women negative for chlamydia and gonorrhea, the relative risk (adjusted incidence rate ratio) of PID was 4.29 (95% confidence interval [CI], 3.66-5.03) in women who were both chlamydia and gonorrhea positive; 4.54 (95% CI, 3.87-5.33) in those only gonorrhea positive; and 1.77 (95% CI, 1.61-1.94) in those only chlamydia positive. CONCLUSIONS: Gonorrhea infection conferred a substantially higher risk than chlamydia of hospitalization or emergency department presentation for PID. The emergence of gonorrhea antimicrobial resistance may have a serious impact on rates of PID and its associated reproductive health sequelae.
引用
- Reekie J, Donovan B, Guy R, et al. Risk of Pelvic Inflammatory Disease in Relation to Chlamydia and Gonorrhea Testing, Repeat Testing, and Positivity: A Population-Based Cohort Study. Clin Infect Dis. 2018. PMID: 29136127. doi:10.1093/cid/cix769
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。